HomeMarketsSharesEaton Vance Enhanced Equity Income Fund II

Trade Eaton Vance Enhanced Equity Income Fund II - EOS CFD

21.67+1.78%
The chart shows the EOS stock price data over the last 1 day, with a current price of 21.67, a high of 21.42, and a low of 21.29.
Low: 21.29High: 21.42
Sellers:
0%
Buyers:
100%
Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.32
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022207 %
(-$4.44)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02221%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000015 %
(-$0.00)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.00002%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close20.8
Open21.29
1-Year Change-11.33%
Day's Range21.29 - 21.42

Trade Eaton Vance Enhanced Equity Income Fund II - EOS

About Eaton Vance Enhanced Equity Incm. Fd. II

Eaton Vance Enhanced Equity Income Fund II (the Fund) is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. The Fund invests primarily in a portfolio of mid-and large-capitalization common stocks. Under normal market conditions, the Fund seeks to generate current earnings from option premiums by selling covered call options on a substantial portion of its portfolio securities. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. The Fund invests primarily in common stocks of the United States issuers, although the Fund may invest up to 25% of its total assets in securities of foreign issuers, including American Depositary Receipts (ADRs) and others. In addition, the Fund may invest up to 20% of its total assets in other derivative instruments. The Fund's investment adviser is Eaton Vance Management.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Eaton Vance Enhanced Equity Incm. Fd. II revenues increased 25% to $8.2M. Net income decreased 18% to $194.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Investments decrease of 46% to $127.7M (income), Unrealized-Written options decrease of 25% to $984K (income).

Latest shares articles

A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
12:41, 7 October 2026
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:18, 7 October 2026
Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:43, 6 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready